Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SNGX Soligenix, Inc.

交易中 05-08 14:58:17 EDT

0.2942

-0.0140

-4.54%

最高0.3300	最低0.2903	成交量71.50万
今开0.3110	昨收0.3082	日振幅12.88%
总市值303.20万	流通市值287.15万	总股本1,031万
成交额21.36万	换手率7.33%	流通股本976.05万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SNGX","market":"US","secType":"STK","nameCN":"Soligenix, Inc.","latestPrice":0.2942,"timestamp":1778266617879,"preClose":0.3082,"halted":0,"volume":714960,"delay":0,"changeRate":-0.045425048669694865,"floatShares":9760500,"shares":10306079,"eps":-2.14,"marketStatus":"交易中","change":-0.014,"latestTime":"05-08 14:58:17 EDT","open":0.311,"high":0.33,"low":0.2903,"amount":213566.98852800002,"amplitude":0.128812,"askPrice":0.296,"askSize":100,"bidPrice":0.2951,"bidSize":88,"shortable":3,"etf":0,"ttmEps":-2.14,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1778270400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.3082,"preHourTrading":{"tag":"盘前","latestPrice":0.3035,"preClose":0.3082,"latestTime":"09:25 EDT","volume":24724,"amount":7798.94301032,"timestamp":1778246726738,"change":-0.0047,"changeRate":-0.01525,"amplitude":0.102206},"postHourTrading":{"tag":"盘后","latestPrice":0.3085,"preClose":0.3082,"latestTime":"19:58 EDT","volume":22379,"amount":6980.30397,"timestamp":1778198330052,"change":0.0003,"changeRate":0.000973,"amplitude":0.071382},"volumeRatio":0.910111},"requestUrl":"/m/hq/s/SNGX/tweets","defaultTab":"tweets","newsList":[{"id":"1168722326","title":"Soligenix公布Hybryte™治疗皮肤T细胞淋巴瘤三期FLASH2试验中期结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1168722326","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168722326?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:33","pubTimestamp":1777375986,"startTime":"0","endTime":"0","summary":"生物制药公司Soligenix近日披露了其核心产品Hybryte™在治疗皮肤T细胞淋巴瘤（CTCL）的三期FLASH2临床试验中取得的中期分析数据。这项关键性研究旨在评估该光动力疗法对早期疾病患者的有效性与安全性。\n最新数据显示，Hybryte™在主要临床终点指标上展现出积极趋势，包括病灶面积减少率和患者应答持续时间等参数。中期结果为进一步验证该创新疗法的临床价值提供了重要依据。\n皮肤T细胞淋巴瘤作为一种罕见皮肤癌，长期面临治疗选择有限的挑战。若最终试验结果达到预期，Hybryte™有望为患者提供新的非侵入性治疗选择。公司表示将继续推进试验进程，并在获得完整数据后向监管机构提交申报材料。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148947807","title":"Soligenix获欧盟授予SGX945治疗白塞病孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1148947807","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148947807?lang=zh_cn&edition=full","pubTime":"2026-03-26 19:31","pubTimestamp":1774524673,"startTime":"0","endTime":"0","summary":"Soligenix公司近日宣布，其研发药物SGX945已获得欧盟委员会颁发的孤儿药资格认定，适应症为白塞病。该认定将加速SGX945在欧洲的临床开发与审批进程，为患者提供新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155823585","title":"Hybryte™疗法研究成果将于2026年美国皮肤淋巴瘤联盟年度研讨会公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1155823585","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155823585?lang=zh_cn&edition=full","pubTime":"2026-03-23 19:32","pubTimestamp":1774265536,"startTime":"0","endTime":"0","summary":"Soligenix, Inc. 旗下Hybryte™疗法的临床研究成果，已确认将于2026年美国皮肤淋巴瘤联盟年度研讨会上正式发布。这一重要数据的公布，预示着该创新疗法在皮肤淋巴瘤治疗领域的最新进展将获得行业权威平台的集中展示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166803274","title":"Soligenix公司宣布Sgx945获英国药品和保健品监管局授予“前景看好的创新药物”资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1166803274","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166803274?lang=zh_cn&edition=full","pubTime":"2026-03-10 19:33","pubTimestamp":1773142381,"startTime":"0","endTime":"0","summary":"Soligenix, Inc. (简称Soligenix) 近日公布，其研发的药物Sgx945已获得英国药品和保健品监管局（MHRA）颁发的“前景看好的创新药物”（Promising Innovative Medicine, PIM）资格认定。这一认定标志着该药物在治疗严重疾病方面展现出显著潜力，并有望加速其在英国的开发和审批进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127152482","title":"Soligenix获欧洲药品管理局支持 SGX945治疗白塞病获孤儿药资格认定积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=1127152482","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127152482?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:35","pubTimestamp":1772109315,"startTime":"0","endTime":"0","summary":"生物制药公司Soligenix, Inc.近日宣布，其研发的SGX945用于治疗白塞病（Behçet's Disease）的孤儿药资格认定申请，已获得欧洲药品管理局（EMA）的积极评价。\n这一重要进展意味着SGX945在针对这一罕见炎症性疾病的开发进程中迈出了关键一步。孤儿药资格认定旨在鼓励针对罕见疾病的药物研发，通常能为企业带来包括市场独占期在内的多项政策利好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177202015","title":"Soligenix持续评估潜在战略选项，涵盖合作及并购机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1177202015","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177202015?lang=zh_cn&edition=full","pubTime":"2026-02-12 20:37","pubTimestamp":1770899829,"startTime":"0","endTime":"0","summary":"Soligenix, Inc. 近日透露，公司正在持续对其潜在的战略选项进行全面评估。这些战略方向广泛，不仅限于寻求合作伙伴关系，还包括探索各类并购机会。此举表明该公司正积极谋划未来发展路径，以增强企业竞争力和市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186113387","title":"Sgx945治疗贝赫切特病的二期临床试验积极结果发表在《牛津风湿病学》","url":"https://stock-news.laohu8.com/highlight/detail?id=1186113387","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186113387?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:33","pubTimestamp":1766061210,"startTime":"0","endTime":"0","summary":"Sgx945治疗贝赫切特病的二期临床试验积极结果发表在《牛津风湿病学》","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110318372","title":"Soligenix公布SGX302二期A期研究的关键结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1110318372","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110318372?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:11","pubTimestamp":1765977097,"startTime":"0","endTime":"0","summary":"12月17日 - Soligenix Inc :: *Soligenix公布SGX302（合成高超越素）在轻度至中度牛皮癣患者中的二期A期研究的关键结果*Soligenix Inc - 优化的凝胶配方在第三组显示出成功*Soligenix Inc - SGX302凝胶疗法耐受性良好且无不良事件*Soligenix Inc - 研究确认SGX302改善牛皮癣病灶 ((投资者简报; 电子邮件: reutersinvestor.briefs@thomsonreuters.com)) 来源日期/时间 = 2025年12月17日12:30:00.08 GMT","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145439786","title":"Soligenix公布Sgx302（合成高光素）在中度至轻度银屑病患者中的Ⅱa期研究总体结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1145439786","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145439786?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:35","pubTimestamp":1765974916,"startTime":"0","endTime":"0","summary":"Soligenix公布Sgx302（合成高光素）在中度至轻度银屑病患者中的Ⅱa期研究总体结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115608124","title":"Soligenix达成Enrollment里程碑，计划进行Hybryte™治疗皮肤T细胞淋巴瘤的确认性第三阶段临床试验中期分析","url":"https://stock-news.laohu8.com/highlight/detail?id=1115608124","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115608124?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:31","pubTimestamp":1763555471,"startTime":"0","endTime":"0","summary":"Soligenix达成Enrollment里程碑，计划进行Hybryte™治疗皮肤T细胞淋巴瘤的确认性第三阶段临床试验中期分析","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511612939","title":"Soligenix, Inc.盘中异动 股价大跌6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511612939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511612939?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:36","pubTimestamp":1739565390,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时36分，Soligenix, Inc.股票出现波动，股价大幅跳水6.10%。Soligenix, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。其相关个股中，Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Allogene Therapeutics, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3195.82%、818.69%、638.68%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为74.35%、71.65%、66.45%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215043630abcf5375&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215043630abcf5375&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511574394","title":"Soligenix, Inc.盘中异动 快速上涨5.22%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511574394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511574394?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:58","pubTimestamp":1739476680,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时58分，Soligenix, Inc.股票出现波动，股价快速拉升5.22%。截至发稿，该股报2.42美元/股，成交量1.931万股，换手率0.77%，振幅4.17%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Moleculin Biotech, Inc.、Dominari Holdings Inc.、Edesa Biotech, Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3228.75%、2127.47%、1245.15%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021403580098846af8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021403580098846af8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508212344","title":"Soligenix, Inc.盘中异动 股价大跌5.15%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508212344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508212344?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:04","pubTimestamp":1738602274,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日01时04分，Soligenix, Inc.股票出现异动，股价快速下挫5.15%。截至发稿，该股报2.21美元/股，成交量3.0778万股，换手率1.23%，振幅4.29%。Soligenix, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为652.11%、451.66%、395.03%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、75.23%、63.94%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204010434987984ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204010434987984ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507622260","title":"Soligenix, Inc.盘中异动 股价大跌5.99%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507622260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507622260?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:16","pubTimestamp":1738250189,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时16分，Soligenix, Inc.股票出现异动，股价急速下挫5.99%。截至发稿，该股报2.28美元/股，成交量5061股，换手率0.20%，振幅2.48%。Soligenix, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1413.79%、178.61%、177.43%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited、Kazia Therapeutics Limited，振幅分别为56.41%、52.92%、42.03%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231630961442da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231630961442da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506584953","title":"Soligenix, Inc.盘中异动 股价大跌5.08%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506584953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506584953?lang=zh_cn&edition=full","pubTime":"2025-01-28 04:27","pubTimestamp":1738009626,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日04时27分，Soligenix, Inc.股票出现波动，股价快速跳水5.08%。截至发稿，该股报2.43美元/股，成交量3.6432万股，换手率1.45%，振幅5.66%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2199.67%、1101.78%、270.93%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.60%、99.77%、65.16%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012804270696126c72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012804270696126c72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505930010","title":"Soligenix, Inc.盘中异动 早盘急速跳水5.28%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505930010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505930010?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:15","pubTimestamp":1737645345,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时15分，Soligenix, Inc.股票出现异动，股价急速下跌5.28%。截至发稿，该股报2.33美元/股，成交量8342股，换手率0.33%，振幅4.47%。Soligenix, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Hepion Pharmaceuticals, Inc.、Nutriband Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3062.99%、600.16%、59.65%，振幅较大的相关个股有Jupiter Neurosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts ，振幅分别为55.57%、54.22%、49.73%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123231545a22d12da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123231545a22d12da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505726090","title":"Soligenix, Inc.盘中异动 股价大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505726090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505726090?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:33","pubTimestamp":1737556437,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时33分，Soligenix, Inc.股票出现波动，股价急速拉升6.25%。截至发稿，该股报2.55美元/股，成交量6954股，换手率0.28%，振幅0.00%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Immunoprecise Antibodies Ltd.、Nutriband Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为463.92%、96.45%、53.77%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Nutriband Inc.、Genelux Corporation，振幅分别为27.53%、17.27%、14.89%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223357986f7808&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223357986f7808&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505470271","title":"Soligenix, Inc.盘中异动 快速下跌5.05%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505470271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505470271?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:45","pubTimestamp":1737470705,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时45分，Soligenix, Inc.股票出现异动，股价快速下跌5.05%。截至发稿，该股报2.23美元/股，成交量1.6452万股，换手率0.66%，振幅5.90%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Channel Therapeutics Corporation、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Replimune Group, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为595.36%、164.28%、50.30%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Atara Biotherapeutics, Inc.，振幅分别为73.16%、38.48%、17.50%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224506a22a5a13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224506a22a5a13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504173301","title":"Soligenix, Inc.盘中异动 股价大涨5.29%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504173301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504173301?lang=zh_cn&edition=full","pubTime":"2025-01-18 03:11","pubTimestamp":1737141082,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日03时11分，Soligenix, Inc.股票出现波动，股价大幅上涨5.29%。截至发稿，该股报2.39美元/股，成交量7.9239万股，换手率3.16%，振幅7.49%。Soligenix, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118031122986a4ef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118031122986a4ef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504944289","title":"Soligenix, Inc.盘中异动 大幅拉升5.29%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504944289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504944289?lang=zh_cn&edition=full","pubTime":"2025-01-17 03:40","pubTimestamp":1737056450,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日03时40分，Soligenix, Inc.股票出现波动，股价快速拉升5.29%。截至发稿，该股报2.39美元/股，成交量14.4033万股，换手率5.74%，振幅7.49%。Soligenix, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Soligenix, Inc.公司简介：Soligenix Inc是一家总部位于美国的后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117034050a224a216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117034050a224a216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.soligenix.com","stockEarnings":[{"period":"1week","weight":-0.1067},{"period":"1month","weight":-0.7296},{"period":"3month","weight":-0.7273},{"period":"6month","weight":-0.775},{"period":"1year","weight":-0.8436},{"period":"ytd","weight":-0.77}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.1098},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.3037},{"period":"ytd","weight":0.0728}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Soligenix, Inc.成立于1987年，是一家临床阶段生物制药公司，专注于开发产品，治疗癌症和严重的胃肠道疾病的治疗所产生的危及生命的副作用（仍然是一个未满足的医疗需求），以及开发多种生物防御疫苗和疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.084195},{"month":2,"riseRate":0.5,"avgChangeRate":-0.039075},{"month":3,"riseRate":0.2,"avgChangeRate":-0.083128},{"month":4,"riseRate":0.1,"avgChangeRate":-0.198653},{"month":5,"riseRate":0.2,"avgChangeRate":-0.117109},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.120983},{"month":7,"riseRate":0.777778,"avgChangeRate":0.373996},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.061062},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.065432},{"month":10,"riseRate":0.222222,"avgChangeRate":0.004798},{"month":11,"riseRate":0.555556,"avgChangeRate":0.121738},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.126538}],"exchange":"NASDAQ","name":"Soligenix, Inc.","nameEN":"Soligenix, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Soligenix, Inc.(SNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Soligenix, Inc.,SNGX,Soligenix, Inc.股票,Soligenix, Inc.股票老虎,Soligenix, Inc.股票老虎国际,Soligenix, Inc.行情,Soligenix, Inc.股票行情,Soligenix, Inc.股价,Soligenix, Inc.股市,Soligenix, Inc.股票价格,Soligenix, Inc.股票交易,Soligenix, Inc.股票购买,Soligenix, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Soligenix, Inc.(SNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}